Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
8182 | 1210 | 32.0 | 68% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
232 | 19686 | TAMOXIFEN//AROMATASE INHIBITORS//ANASTROZOLE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ANTIPROGESTIN | Author keyword | 52 | 60% | 5% | 57 |
2 | MIFEPRISTONE | Author keyword | 38 | 20% | 14% | 172 |
3 | ONAPRISTONE | Author keyword | 25 | 66% | 2% | 23 |
4 | PROGESTERONE ANTAGONISTS | Author keyword | 19 | 74% | 1% | 14 |
5 | ANTIPROGESTINS | Author keyword | 17 | 40% | 3% | 34 |
6 | PROGESTERONE RECEPTOR MODULATORS | Author keyword | 13 | 67% | 1% | 12 |
7 | PROGESTERONE ANTAGONIST | Author keyword | 12 | 63% | 1% | 12 |
8 | ANORDIOL | Author keyword | 12 | 86% | 0% | 6 |
9 | ASOPRISNIL | Author keyword | 11 | 67% | 1% | 10 |
10 | RU486 | Author keyword | 10 | 18% | 4% | 49 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ANTIPROGESTIN | 52 | 60% | 5% | 57 | Search ANTIPROGESTIN | Search ANTIPROGESTIN |
2 | MIFEPRISTONE | 38 | 20% | 14% | 172 | Search MIFEPRISTONE | Search MIFEPRISTONE |
3 | ONAPRISTONE | 25 | 66% | 2% | 23 | Search ONAPRISTONE | Search ONAPRISTONE |
4 | PROGESTERONE ANTAGONISTS | 19 | 74% | 1% | 14 | Search PROGESTERONE+ANTAGONISTS | Search PROGESTERONE+ANTAGONISTS |
5 | ANTIPROGESTINS | 17 | 40% | 3% | 34 | Search ANTIPROGESTINS | Search ANTIPROGESTINS |
6 | PROGESTERONE RECEPTOR MODULATORS | 13 | 67% | 1% | 12 | Search PROGESTERONE+RECEPTOR+MODULATORS | Search PROGESTERONE+RECEPTOR+MODULATORS |
7 | PROGESTERONE ANTAGONIST | 12 | 63% | 1% | 12 | Search PROGESTERONE+ANTAGONIST | Search PROGESTERONE+ANTAGONIST |
8 | ANORDIOL | 12 | 86% | 0% | 6 | Search ANORDIOL | Search ANORDIOL |
9 | ASOPRISNIL | 11 | 67% | 1% | 10 | Search ASOPRISNIL | Search ASOPRISNIL |
10 | RU486 | 10 | 18% | 4% | 49 | Search RU486 | Search RU486 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | RU486 | 97 | 49% | 12% | 143 |
2 | RU 486 | 95 | 39% | 16% | 193 |
3 | LOW DOSE MIFEPRISTONE | 66 | 54% | 7% | 84 |
4 | ANTIPROGESTERONE RU 486 | 49 | 78% | 3% | 32 |
5 | PROGESTERONE ANTAGONISTS | 41 | 60% | 4% | 45 |
6 | PROGESTERONE ANTAGONIST RU 486 | 40 | 79% | 2% | 26 |
7 | ANTIPROGESTINS | 40 | 61% | 4% | 43 |
8 | ANTIPROGESTIN RU 486 | 35 | 89% | 1% | 16 |
9 | PENICILLIUM OBLATUM | 21 | 85% | 1% | 11 |
10 | ANTIPROGESTERONE RU486 | 20 | 51% | 2% | 28 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Antiprogestins in gynecological diseases | 2015 | 1 | 197 | 45% |
RU486 (mifepristone): Mechanisms of action and clinical uses | 1997 | 213 | 143 | 50% |
Mifepristone (RU 486) in Cushing's syndrome | 2007 | 47 | 44 | 84% |
A review of the endometrial histologic effects of progestins and progesterone receptor modulators in reproductive age women | 2015 | 1 | 37 | 30% |
Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications | 2005 | 119 | 139 | 46% |
Mifepristone (RU486): a review | 1997 | 93 | 58 | 64% |
DRUG-THERAPY - MIFEPRISTONE (RU-486) - A MODULATOR OF PROGESTIN AND GLUCOCORTICOID ACTION | 1993 | 124 | 80 | 80% |
Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis | 2005 | 130 | 110 | 30% |
Vaginal ring delivery of selective progesterone receptor modulators for contraception | 2013 | 5 | 20 | 55% |
Clinical pharmacokinetics of mifepristone | 1997 | 43 | 54 | 76% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CONTRACEPT DEV NETWORK | 3 | 31% | 0.7% | 8 |
2 | POST GYNAECOL OBSTETR | 2 | 67% | 0.2% | 2 |
3 | FERTIL CONTROL HORMONE THER Y | 2 | 43% | 0.2% | 3 |
4 | SHANGHAI FAMILY PLANNING TECH RUCT | 2 | 33% | 0.3% | 4 |
5 | JONES REPROD MED OBSTET GYNECOL | 1 | 38% | 0.2% | 3 |
6 | EQUIPE ACCUEIL 1533 | 1 | 100% | 0.2% | 2 |
7 | MED CHEM STEROID | 1 | 50% | 0.2% | 2 |
8 | OBSTET GYNECOL REPROD MED PUBL HLTH | 1 | 100% | 0.2% | 2 |
9 | UNIDAD INVEST BIOMED CANC INCAN | 1 | 50% | 0.2% | 2 |
10 | PRIMATE IL | 1 | 40% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000198022 | PROGESTERONE RECEPTOR ISOFORMS//PROGINS//PROGESTERONE RECEPTOR A |
2 | 0.0000135349 | MEDICAL ABORTION//MISOPROSTOL//MIFEPRISTONE |
3 | 0.0000120632 | EMERGENCY CONTRACEPTION//POSTCOITAL CONTRACEPTION//MORNING AFTER PILL |
4 | 0.0000102406 | ENDOMETRIAL BLEEDING//BREAKTHROUGH BLEEDING//SYDNEY REPROD HLTH |
5 | 0.0000077500 | INSERM E9912//ZK 91587//LIALH4 REDUCTION |
6 | 0.0000071588 | CERVICAL REMODELING//CERVICAL RIPENING//HUMAN UTERINE CERVIX |
7 | 0.0000068824 | SELECTIVE ANDROGEN RECEPTOR MODULATOR//SARM//SARMS |
8 | 0.0000067462 | CENTCHROMAN//DL111 IT//ORMELOXIFENE |
9 | 0.0000061643 | ESTROGEN RECEPTOR ACTIVATION FACTOR//NUCLEAR ESTROGEN RECEPTOR II//NON ACTIVATED ESTROGEN RECEPTOR |
10 | 0.0000061429 | ESTROGEN RECEPTOR RELATED ANTIGEN//AUTOCRINE SYSTEM//BRAIN TUMOUR EPIDEMIOLOGY |